Background: Cerebral edema is a well-recognized and potentially fatal complication of acute liver failure (ALF). The effectiveness of treatments that address intracranial hypertension is generally assessed by measuring intracranial pressure (ICP). The aim of this study was to determine the role of cerebral microdialysis in monitoring the efficacy of fractionated plasma separation and adsorption (FPSA) treatment for ALF. We hypothesized that in ALF cerebral microdialysis reflects the benefits of FPSA treatment on cerebral edema before ICP.
Methods: A surgical resection model of ALF was used in 21 pigs. We measured plasma ammonia concentration, brain concentrations of glucose, lactate, pyruvate, glutamate and glutamine, and ICP. Animals were randomized into three groups: in one group eight animals received 6 hours of FPSA treatment 2 hours after induction of ALF; in another group 10 animals received supportive treatment for ALF only; and in the final group three underwent sham surgery.
Results: The ICP was significantly higher in the ALF group than in the FPSA group 9 hours after surgery. The lactate/pyruvate (L/P) ratio was significantly lower in the FPSA group than the ALF group 5 hours after surgery, before any significant difference in ICP was detected. Indeed, significant changes in the L/P ratio could be observed within 1 hour of treatment. Glutamine levels were significantly lower in the FPSA group than the ALF group between 6 hours and 10 hours after surgery.
Conclusions: Brain lactate/pyruvate ratio and concentration of glutamine measured by cerebral microdialysis reflected the beneficial effects of FPSA treatment on cerebral metabolism more precisely and rapidly than ICP in pigs with fulminant ALF. The role of glutamine as a marker of the efficacy of FPSA treatment for ALF appears promising, but needs further evaluation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691596 | PMC |
| http://dx.doi.org/10.1186/1471-230X-13-98 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study.
World J Surg Oncol
December 2024
Department of Urology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Background: To assess the clinical utility of PCA3 in the diagnostic accuracy, the correlation between PCA3 and biopsy or pathological characteristics and the performance of PCA3 to reduce the unnecessary biopsies in Chinese population.
Methods: A prospective study including patients with indication of prostate biopsies from 4 centers was conducted. All patients underwent PCA3 urine tests and prostate biopsies.
The Predictive Value of tPSA, fPSA, fPSA/tPSA Combined with Ultrasound Parameters in Postoperative Gleason Grading of Prostate Cancer.
Ann Ital Chir
December 2024
Endocrine Tumor Intervention Department, Jinan Central Hospital, Central Hospital Affiliated to Shandong First Medical University, 250013 Jinan, Shandong, China.
Aim: Prostate cancer (PCa) is a common malignant tumor in men. This study aimed to explore the predictive value of serum biomarkers combined with ultrasound parameters for postoperative Gleason grading in PCa.
Methods: This study included 65 PCa patients who underwent transurethral resection of the prostate in our hospital from January 2021 to December 2023.
Diagnostic Value of Radiomics Based on Various Diffusion Models in Magnetic Resonance Imaging for Prostate Cancer Risk Stratification.
Curr Med Imaging
November 2024
Department of Radiology, Dahua Hospital, Xuhui District, Shanghai, 200237, China.
Introduction: The use of Magnetic Resonance Imaging (MRI) and radiomics improves the management of Prostate Cancer (PCa) and helps in differentiating between clinically insignificant and significant PCa. This study has explored the diagnostic value of radiomic analysis based on functional parameter maps from monoexponential and diffusion kurtosis models in MRI for differentiating between clinically insignificant and significant PCa.
Methods: In total, 105 PCa cases, including 38 clinically insignificant and 67 clinically significant PCa cases, were retrospectively analyzed.
Machine learning discrimination of Gleason scores below GG3 and above GG4 for HSPC patients diagnosis.
Sci Rep
October 2024
Department of Urology I, The Third Affiliated Hospital of Kunming Medical University (Peking University Cancer Hospital Yunnan, Yunnan Cancer Hospital, Cancer Center of Yunnan Province), 519 Kunzhou Road, Kunming, 650199, Yunnan, China.
Article Synopsis
- This study develops machine learning models to analyze Gleason scores in prostate cancer by using data from 526 hormone-sensitive prostate cancer patients at Yunnan Cancer Hospital.
- Seven different machine learning methods, including Random Forest and XGBoost, were employed and evaluated based on various metrics such as accuracy and area under the curve, with Random Forest performing the best.
- The study highlights important clinical features such as bone metastases and prostatic volume, suggesting that ensemble learning techniques can effectively identify significant predictors in prostate cancer outcomes.
Cell calcification reverses the chemoresistance of cancer cells via the conversion of glycolipid metabolism.
Biomaterials
March 2025
Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China; Institute of Translational Medicine, Zhejiang University, Hangzhou, 310029, China; State Key Laboratory of Transvascular Implantation Devices, Hangzhou, 310009, China; Zhejiang Key Laboratory of Frontier Medical Research on Cancer Metabolism, Hangzhou, 310029, China; Cancer Center, Zhejiang University, Hangzhou, 310029, China. Electronic address:
Article Synopsis
- Drug resistance in cancer chemotherapy is a major issue, with cancer cells often shifting to fatty acid metabolism to evade treatment.
- The researchers created a drug called folate-polySia (FpSA) that induces microcalcification in cervical cancer cells resistant to cisplatin, leading to decreased fatty acid uptake and increased glycolysis.
- The combination of cisplatin and FpSA not only inhibited tumor growth but also improved survival rates in mice, suggesting a new strategy to tackle chemotherapy-resistant tumors by reprogramming cancer cell metabolism.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!